InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Segal Jeffrey, 董事. Insider active across 1 company, notably INVO Bioscience, Inc.. In total, 2 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 15 January 2022. The latest transaction was disclosed on 1 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Segal Jeffrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
9,211 股@ US$0.95100.0% 占其流量Common StockSEC:0001493152-22-015908:0
标准退出：2022年8月30日 (T+90)
8,034 股0Common StockSEC:0001493152-22-001534:0
2 条申报中的 2 条
About Segal Jeffrey
Jeffrey Segal is a Director at INVO Bioscience, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the biotechnology sector allows him to provide valuable insights into the development of new treatments.
